vs

Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Information Services Group Inc. (III). Click either name above to swap in a different company.

Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $61.2M, roughly 1.0× Information Services Group Inc.). Information Services Group Inc. runs the higher net margin — 4.3% vs -70.9%, a 75.2% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 5.9%). Information Services Group Inc. produced more free cash flow last quarter ($4.3M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -2.4%).

Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

CTKB vs III — Head-to-Head

Bigger by revenue
CTKB
CTKB
1.0× larger
CTKB
$62.1M
$61.2M
III
Growing faster (revenue YoY)
CTKB
CTKB
+2.2% gap
CTKB
8.1%
5.9%
III
Higher net margin
III
III
75.2% more per $
III
4.3%
-70.9%
CTKB
More free cash flow
III
III
$6.1M more FCF
III
$4.3M
$-1.8M
CTKB
Faster 2-yr revenue CAGR
CTKB
CTKB
Annualised
CTKB
17.7%
-2.4%
III

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTKB
CTKB
III
III
Revenue
$62.1M
$61.2M
Net Profit
$-44.1M
$2.6M
Gross Margin
52.9%
44.8%
Operating Margin
-9.0%
8.4%
Net Margin
-70.9%
4.3%
Revenue YoY
8.1%
5.9%
Net Profit YoY
-557.1%
-14.1%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTKB
CTKB
III
III
Q4 25
$62.1M
$61.2M
Q3 25
$52.3M
$62.4M
Q2 25
$45.6M
$61.6M
Q1 25
$41.5M
$59.6M
Q4 24
$57.5M
$57.8M
Q3 24
$51.5M
$61.3M
Q2 24
$46.6M
$64.3M
Q1 24
$44.9M
$64.3M
Net Profit
CTKB
CTKB
III
III
Q4 25
$-44.1M
$2.6M
Q3 25
$-5.5M
$3.1M
Q2 25
$-5.6M
$2.2M
Q1 25
$-11.4M
$1.5M
Q4 24
$9.6M
$3.0M
Q3 24
$941.0K
$1.1M
Q2 24
$-10.4M
$2.0M
Q1 24
$-6.2M
$-3.4M
Gross Margin
CTKB
CTKB
III
III
Q4 25
52.9%
44.8%
Q3 25
52.7%
42.2%
Q2 25
52.3%
42.2%
Q1 25
48.6%
43.1%
Q4 24
58.5%
41.5%
Q3 24
56.3%
40.4%
Q2 24
54.6%
39.5%
Q1 24
51.3%
36.1%
Operating Margin
CTKB
CTKB
III
III
Q4 25
-9.0%
8.4%
Q3 25
-17.6%
7.4%
Q2 25
-23.3%
7.6%
Q1 25
-36.1%
5.7%
Q4 24
5.2%
0.3%
Q3 24
-8.2%
7.0%
Q2 24
-18.3%
5.7%
Q1 24
-23.9%
-3.7%
Net Margin
CTKB
CTKB
III
III
Q4 25
-70.9%
4.3%
Q3 25
-10.5%
4.9%
Q2 25
-12.2%
3.5%
Q1 25
-27.5%
2.5%
Q4 24
16.8%
5.3%
Q3 24
1.8%
1.9%
Q2 24
-22.4%
3.2%
Q1 24
-13.8%
-5.3%
EPS (diluted)
CTKB
CTKB
III
III
Q4 25
$0.06
Q3 25
$0.06
Q2 25
$0.04
Q1 25
$0.03
Q4 24
$0.07
Q3 24
$0.02
Q2 24
$0.04
Q1 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTKB
CTKB
III
III
Cash + ST InvestmentsLiquidity on hand
$90.9M
$28.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$341.7M
$94.7M
Total Assets
$461.5M
$211.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTKB
CTKB
III
III
Q4 25
$90.9M
$28.7M
Q3 25
$93.3M
$28.7M
Q2 25
$75.5M
$25.2M
Q1 25
$95.3M
$20.1M
Q4 24
$98.7M
$23.1M
Q3 24
$162.3M
$9.7M
Q2 24
$177.9M
$11.8M
Q1 24
$168.8M
$14.0M
Stockholders' Equity
CTKB
CTKB
III
III
Q4 25
$341.7M
$94.7M
Q3 25
$378.6M
$94.7M
Q2 25
$377.6M
$94.1M
Q1 25
$379.6M
$95.0M
Q4 24
$395.7M
$96.3M
Q3 24
$385.5M
$96.6M
Q2 24
$389.1M
$95.5M
Q1 24
$392.6M
$95.6M
Total Assets
CTKB
CTKB
III
III
Q4 25
$461.5M
$211.0M
Q3 25
$494.9M
$213.3M
Q2 25
$493.3M
$200.7M
Q1 25
$482.6M
$202.4M
Q4 24
$499.5M
$204.5M
Q3 24
$491.2M
$227.1M
Q2 24
$483.7M
$235.3M
Q1 24
$492.1M
$234.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTKB
CTKB
III
III
Operating Cash FlowLast quarter
$-771.0K
$5.1M
Free Cash FlowOCF − Capex
$-1.8M
$4.3M
FCF MarginFCF / Revenue
-2.9%
7.0%
Capex IntensityCapex / Revenue
1.6%
1.2%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$-8.8M
$25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTKB
CTKB
III
III
Q4 25
$-771.0K
$5.1M
Q3 25
$-3.9M
$11.1M
Q2 25
$108.0K
$11.9M
Q1 25
$-125.0K
$978.0K
Q4 24
$2.0M
$6.6M
Q3 24
$13.2M
$8.8M
Q2 24
$6.2M
$2.2M
Q1 24
$4.0M
$2.3M
Free Cash Flow
CTKB
CTKB
III
III
Q4 25
$-1.8M
$4.3M
Q3 25
$-4.6M
$9.5M
Q2 25
$-1.5M
$11.1M
Q1 25
$-974.0K
$141.0K
Q4 24
$1.1M
$6.0M
Q3 24
$12.2M
$8.4M
Q2 24
$5.2M
$1.3M
Q1 24
$3.4M
$1.3M
FCF Margin
CTKB
CTKB
III
III
Q4 25
-2.9%
7.0%
Q3 25
-8.7%
15.2%
Q2 25
-3.2%
18.0%
Q1 25
-2.3%
0.2%
Q4 24
1.9%
10.4%
Q3 24
23.7%
13.7%
Q2 24
11.0%
2.0%
Q1 24
7.6%
2.0%
Capex Intensity
CTKB
CTKB
III
III
Q4 25
1.6%
1.2%
Q3 25
1.3%
2.5%
Q2 25
3.5%
1.4%
Q1 25
2.0%
1.4%
Q4 24
1.6%
0.9%
Q3 24
2.0%
0.6%
Q2 24
2.3%
1.4%
Q1 24
1.3%
1.6%
Cash Conversion
CTKB
CTKB
III
III
Q4 25
1.94×
Q3 25
3.62×
Q2 25
5.46×
Q1 25
0.66×
Q4 24
0.21×
2.15×
Q3 24
14.05×
7.66×
Q2 24
1.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTKB
CTKB

Products$46.6M75%
Services$15.5M25%

III
III

Segment breakdown not available.

Related Comparisons